Dr. Alson Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 14-12-2024
- Paid Up Capital ₹ 1.10 M
as on 14-12-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.90 M
as on 14-12-2024
- Satisfied Charges ₹ 2.70 M
as on 14-12-2024
- Revenue -9.43%
(FY 2018)
- Profit 1.08%
(FY 2018)
- Ebitda 13.93%
(FY 2018)
- Net Worth 1.81%
(FY 2018)
- Total Assets 6.83%
(FY 2018)
About Dr. Alson Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹3.90 M. The company has closed loans amounting to ₹2.70 M, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Gupta and Raj Gupta serve as directors at the Company.
- CIN/LLPIN
U24231DL2002PTC115434
- Company No.
115434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2002
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dr. Alson Laboratories Private Limited offer?
Dr. Alson Laboratories Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Antacid Drugs, Common Disease Medicines, Antihistamines, Vitamin Tablets & Capsules, Nutritional Supplements, Digestive Drugs.
Who are the key members and board of directors at Dr. Alson Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Gupta  | Director | 05-Sep-2004 | Current |
| Raj Gupta | Director | 20-May-2002 | Current |
Financial Performance of Dr. Alson Laboratories.
Dr. Alson Laboratories Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 9.43% decrease. The company also saw a slight improvement in profitability, with a 1.08% increase in profit. The company's net worth moved up by a moderate rise of 1.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Alson Laboratories?
In 2018, Dr. Alson Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alson Distillery Private LimitedActive 5 years 7 monthsSandeep Gupta and Raj Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Mar 2017 | ₹2.70 M | Open |
Punjab National Bank Creation Date: 16 Jul 2009 | ₹1.20 M | Open |
The Federal Bank Ltd. Creation Date: 05 Jan 2006 | ₹1.20 M | Satisfied |
How Many Employees Work at Dr. Alson Laboratories?
Unlock and access historical data on people associated with Dr. Alson Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Alson Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Alson Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
